<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>V8 on BriefTechNews.com</title><link>https://brief-tech-news.com/tags/v8/</link><description>Recent content in V8 on BriefTechNews.com</description><generator>Hugo</generator><language>en</language><copyright>Copyright &amp;copy;2021 &lt;br&gt; Designed &amp;amp; Developed by [Gethugothemes](https://gethugothemes.com/)</copyright><lastBuildDate>Thu, 27 Aug 2026 10:37:28 +0000</lastBuildDate><atom:link href="https://brief-tech-news.com/tags/v8/index.xml" rel="self" type="application/rss+xml"/><item><title>Nvidia's $13B Hugging Face Deal Would Reshape Open-Source AI</title><link>https://brief-tech-news.com/blogs/2026-08-27-tech/</link><pubDate>Thu, 27 Aug 2026 10:37:28 +0000</pubDate><guid>https://brief-tech-news.com/blogs/2026-08-27-tech/</guid><description>Nvidia is in advanced talks to acquire Hugging Face for roughly $13 billion, consolidating the open-source ML model&amp;rsquo;s primary hub under a single GPU vendor and raising questions about platform neutrality, dataset access, and future pricing. OpenAI continues navigating leadership churn and legal battles despite ChatGPT&amp;rsquo;s sustained dominance. Z.ai confirmed it&amp;rsquo;s behind the mysterious Ox Alpha model topping benchmarks, signaling intensifying competition from Chinese AI labs. A new pancreatic cancer drug extending survival to 13 months at $477,000/year highlights the commercial stakes.</description></item></channel></rss>